Jonathan Wong1, Beibei Xu2, Heidi N Yeung3, Eric J Roeland3, Maria Elena Martinez4, Quynh-Thu Le5, Loren K Mell2, James D Murphy6. 1. University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii. 2. Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Moores Cancer Center, University of California San Diego, La Jolla, California. 3. Moores Cancer Center, University of California San Diego, La Jolla, California; Division of Palliative Medicine, Department of Internal Medicine, University of California San Diego, La Jolla, California. 4. Moores Cancer Center, University of California San Diego, La Jolla, California; Department of Family and Preventive Medicine, University of California San Diego, La Jolla, California. 5. Department of Radiation Oncology, Stanford University, Stanford, California. 6. Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Moores Cancer Center, University of California San Diego, La Jolla, California. Electronic address: j2murphy@ucsd.edu.
Abstract
PURPOSE/ OBJECTIVE: Palliative radiation therapy represents an important treatment option among patients with advanced cancer, although research shows decreased use among older patients. This study evaluated age-related patterns of palliative radiation use among an elderly Medicare population. METHODS AND MATERIALS: We identified 63,221 patients with metastatic lung, breast, prostate, or colorectal cancer diagnosed between 2000 and 2007 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Receipt of palliative radiation therapy was extracted from Medicare claims. Multivariate Poisson regression analysis determined residual age-related disparity in the receipt of palliative radiation therapy after controlling for confounding covariates including age-related differences in patient and demographic covariates, length of life, and patient preferences for aggressive cancer therapy. RESULTS: The use of radiation decreased steadily with increasing patient age. Forty-two percent of patients aged 66 to 69 received palliative radiation therapy. Rates of palliative radiation decreased to 38%, 32%, 24%, and 14% among patients aged 70 to 74, 75 to 79, 80 to 84, and over 85, respectively. Multivariate analysis found that confounding covariates attenuated these findings, although the decreased relative rate of palliative radiation therapy among the elderly remained clinically and statistically significant. On multivariate analysis, compared to patients 66 to 69 years old, those aged 70 to 74, 75 to 79, 80 to 84, and over 85 had a 7%, 15%, 25%, and 44% decreased rate of receiving palliative radiation, respectively (all P<.0001). CONCLUSIONS: Age disparity with palliative radiation therapy exists among older cancer patients. Further research should strive to identify barriers to palliative radiation among the elderly, and extra effort should be made to give older patients the opportunity to receive this quality of life-enhancing treatment at the end of life.
PURPOSE/ OBJECTIVE: Palliative radiation therapy represents an important treatment option among patients with advanced cancer, although research shows decreased use among older patients. This study evaluated age-related patterns of palliative radiation use among an elderly Medicare population. METHODS AND MATERIALS: We identified 63,221 patients with metastatic lung, breast, prostate, or colorectal cancer diagnosed between 2000 and 2007 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Receipt of palliative radiation therapy was extracted from Medicare claims. Multivariate Poisson regression analysis determined residual age-related disparity in the receipt of palliative radiation therapy after controlling for confounding covariates including age-related differences in patient and demographic covariates, length of life, and patient preferences for aggressive cancer therapy. RESULTS: The use of radiation decreased steadily with increasing patient age. Forty-two percent of patients aged 66 to 69 received palliative radiation therapy. Rates of palliative radiation decreased to 38%, 32%, 24%, and 14% among patients aged 70 to 74, 75 to 79, 80 to 84, and over 85, respectively. Multivariate analysis found that confounding covariates attenuated these findings, although the decreased relative rate of palliative radiation therapy among the elderly remained clinically and statistically significant. On multivariate analysis, compared to patients 66 to 69 years old, those aged 70 to 74, 75 to 79, 80 to 84, and over 85 had a 7%, 15%, 25%, and 44% decreased rate of receiving palliative radiation, respectively (all P<.0001). CONCLUSIONS: Age disparity with palliative radiation therapy exists among older cancerpatients. Further research should strive to identify barriers to palliative radiation among the elderly, and extra effort should be made to give older patients the opportunity to receive this quality of life-enhancing treatment at the end of life.
Authors: L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt Journal: Int J Radiat Oncol Biol Phys Date: 1997-03-01 Impact factor: 7.038
Authors: Craig C Earle; Bridget A Neville; Mary Beth Landrum; John Z Ayanian; Susan D Block; Jane C Weeks Journal: J Clin Oncol Date: 2004-01-15 Impact factor: 44.544
Authors: Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota Journal: Mech Ageing Dev Date: 2017-05-11 Impact factor: 5.432
Authors: Bin Huang; Therese A Dolecek; Quan Chen; Catherine R Garcia; Thomas Pittman; John L Villano Journal: Med Oncol Date: 2018-04-17 Impact factor: 3.064
Authors: Nwamaka D Eneanya; Susan M Hailpern; Ann M O'Hare; Manjula Kurella Tamura; Ronit Katz; William Kreuter; Maria E Montez-Rath; Paul L Hebert; Yoshio N Hall Journal: Am J Kidney Dis Date: 2016-09-29 Impact factor: 8.860
Authors: Khodayar Goshtasbi; Arash Abiri; Brandon M Lehrich; Mehdi Abouzari; Harrison W Lin; Hamid R Djalilian; Frank P K Hsu; Edward C Kuan Journal: J Clin Neurosci Date: 2021-07-26 Impact factor: 2.116